{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T08:06:24Z","timestamp":1785744384176,"version":"3.56.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":975,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1097\/jto.0b013e318283da3e","type":"journal-article","created":{"date-parts":[[2013,3,22]],"date-time":"2013-03-22T17:35:56Z","timestamp":1363973756000},"page":"469-477","source":"Crossref","is-referenced-by-count":31,"title":["Thymidylate Synthase and Folyl-Polyglutamate Synthase Are Not Clinically Useful Markers of Response to Pemetrexed in Patients with Malignant Pleural Mesothelioma"],"prefix":"10.1016","volume":"8","author":[{"given":"Daniel E. Schwed","family":"Lustgarten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charuhas","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charu","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Chuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassiliki","family":"Saloura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Vachani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Litzky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette","family":"Creaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna K.","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Inghilleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Stella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Albelda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/JTO.0b013e318283da3e_bib1","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318283da3e_bib2","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.clinthera.2005.09.010","article-title":"Pemetrexed: a multitargeted antifolate","volume":"27","author":"Rollins","year":"2005","journal-title":"Clin Ther"},{"key":"10.1097\/JTO.0b013e318283da3e_bib3","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/sj.bjc.6603639","article-title":"Changes in the status of p53 affect drug sensitivity to thymidylate synthase (TS) inhibitors by altering TS levels","volume":"96","author":"Giovannetti","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1097\/JTO.0b013e318283da3e_bib4","first-page":"3533","article-title":"Characterization of a thymidylate synthase (TS)-inducible cell line: a model system for studying sensitivity to TS- and non-TS-targeted chemotherapies","volume":"7","author":"Longley","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1097\/JTO.0b013e318283da3e_bib5","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0006-2952(03)00287-9","article-title":"Induction of resistance to the multitargeted antifolate Pemetrexed (ALIMTA) in WiDr human colon cancer cells is associated with thymidylate synthase overexpression","volume":"66","author":"Sigmond","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1097\/JTO.0b013e318283da3e_bib6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1634\/theoncologist.2008-0232","article-title":"The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies","volume":"14","author":"Scagliotti","year":"2009","journal-title":"Oncologist"},{"key":"10.1097\/JTO.0b013e318283da3e_bib7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/JTO.0b013e3181f7c6d4","article-title":"Treatment-by-histology interaction analyses in three phase III trials show superiority of pemetrexed in nonsquamous non-small cell lung cancer","volume":"6","author":"Scagliotti","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1097\/JTO.0b013e318283da3e_bib8","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/S0140-6736(09)61497-5","article-title":"Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study","volume":"374","author":"Ciuleanu","year":"2009","journal-title":"Lancet"},{"key":"10.1097\/JTO.0b013e318283da3e_bib9","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1002\/cncr.22208","article-title":"Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase","volume":"107","author":"Ceppi","year":"2006","journal-title":"Cancer"},{"key":"10.1097\/JTO.0b013e318283da3e_bib10","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1097\/JTO.0b013e3182208ea8","article-title":"Significance of thymidylate synthase and thyroid transcription factor 1 expression in patients with nonsquamous non-small cell lung cancer treated with pemetrexed-based chemotherapy","volume":"6","author":"Sun","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1097\/JTO.0b013e318283da3e_bib11","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1200\/JCO.2009.25.9275","article-title":"Thymidylate synthase but not excision repair cross-complementation group 1 tumor expression predicts outcome in patients with malignant pleural mesothelioma treated with pemetrexed-based chemotherapy","volume":"28","author":"Righi","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e318283da3e_bib12","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1158\/1078-0432.CCR-10-2873","article-title":"Thymidylate synthase and excision repair cross-complementing group-1 as predictors of responsiveness in mesothelioma patients treated with pemetrexed\/carboplatin","volume":"17","author":"Zucali","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1097\/JTO.0b013e318283da3e_bib13","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1097\/JTO.0b013e318260deaa","article-title":"Folylpoly-glutamate synthetase expression is associated with tumor response and outcome from pemetrexed-based chemotherapy in malignant pleural mesothelioma","volume":"7","author":"Christoph","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1097\/JTO.0b013e318283da3e_bib14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10637-007-9060-9","article-title":"In vitro chemosensitivity of freshly explanted tumor cells to pemetrexed is correlated with target gene expression","volume":"25","author":"Hanauske","year":"2007","journal-title":"Invest New Drugs"},{"key":"10.1097\/JTO.0b013e318283da3e_bib15","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/ijc.10829","article-title":"Loss of folylpoly-gamma-glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates in multiple human leukemia sublines","volume":"103","author":"Liani","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1097\/JTO.0b013e318283da3e_bib16","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1158\/1535-7163.MCT-07-0449","article-title":"Effects of folate and folylpolyglutamyl synthase modulation on chemosensitivity of breast cancer cells","volume":"6","author":"Cho","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1097\/JTO.0b013e318283da3e_bib17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mdh059","article-title":"Modified RECIST criteria for assessment of response in malignant pleural mesothelioma","volume":"15","author":"Byrne","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1097\/JTO.0b013e318283da3e_bib18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/hyb.2007.004","article-title":"Derivation and characterization of monoclonal antibodies against human folypolyglutamate synthetase","volume":"26","author":"Dotzlaf","year":"2007","journal-title":"Hybridoma (Larchmt)"},{"key":"10.1097\/JTO.0b013e318283da3e_bib19","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1210\/jc.2002-021353","article-title":"Sex steroid hormone receptors in human thymoma","volume":"88","author":"Ishibashi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/JTO.0b013e318283da3e_bib20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.lungcan.2011.01.024","article-title":"Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: the association with treatment efficacy of pemetrexed","volume":"74","author":"Chen","year":"2011","journal-title":"Lung Cancer"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415327921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415327921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T04:01:41Z","timestamp":1562817701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086415327921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S1556086415327921"],"URL":"https:\/\/doi.org\/10.1097\/jto.0b013e318283da3e","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}